Certain Options of BioSig Technologies, Inc. are subject to a Lock-Up Agreement Ending on 25-JUL-2022. These Options will be under lockup for 31 days starting from 24-JUN-2022 to 25-JUL-2022.

Details:
Executive officers, directors and certain stockholders have entered into lock-up agreements with the underwriters pursuant to which each of these persons or entities, with limited exceptions, may not, directly or indirectly, without the prior written consent of Laidlaw & Company (UK) Ltd., offer for sale, sell, contract to sell, pledge, or otherwise dispose of, directly or indirectly, any shares of common stock or securities convertible into or exercisable or exchangeable for common stock, for a period of 30 days after the date of the final prospectus supplement for this offering.